Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Home - The Pharma Times | Pharma & Health Care News Portal
Friday, April 26, 2024

Conjunctivitis at its peak by NIIMS

New Delhi, August 17, 2023: Conjunctivitis or pink eyes or red eyes is spreading at a fast rate. It is highly infectious and might...

How to fight piles during lockdown

By Dr. Mahesh Chikkachannappa, Sr. Consultant - General, Laparoscopic & Bariatric Surgery, Aster CMI Hospital Piles, which is a serious health problem, and has many...

Ensuring Safe Delivery during Covid 19 pandemic: Hospitals Adopt Special Measures,...

Rainbow Children's Hospitals witnessed 87 deliveries in the month of March with strict prevention protocols From strict testing before admittance to restricting movement of attendants,...

Biotechnology

Conjunctivitis at its peak by NIIMS

New Delhi, August 17, 2023: Conjunctivitis or pink eyes or red eyes is spreading at a fast rate. It is highly infectious and might...

IT & Software Support

Appointments

Azelis appoints Group Technical Innovation Director, strengthening Azelis’ focus on application and formulation support

Azelis appoints Group Technical Innovation Director, strengthening Azelis’ focus on application and formulation support

New Delhi, September 06, 2019: It is with great pleasure that Azelis announces the appointment of Ron Rosenberg as its Group Technical Innovation Director, effective...

Awards

Financial Results

Hester Biosciences Limited Q2 & H1 FY23 Results

Standalone revenue up by 27% and 6% for Q2 and H1 FY23  Consolidated revenue up by...

Hester Biosciences Ltd reports Net Profit of Rs. 3.56 crore and Revenues from Operations of Rs. 50.7 crore in Q1FY23

Ahmedabad, August 11, 2022: One of India's leading poultry and animal vaccine manufacturing company, Hester Biosciences Limited has...

Lincoln Pharmaceuticals Ltd reports Standalone Net Profit of Rs. 28.04 crore in Q3 FY24, 29.75% rise Y-o-Y

New Delhi, February 09, 2024: Company achieved Profit Before Tax of Rs. 100.02 crores for...

Approvals

Clinical Trails

Phase III DECISION Trial of Nexavar® (sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival...

Berlin, January 3, 2013 – Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that a Phase III trial of Nexavar® (sorafenib) tablets in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory differentiated thyroid cancer has met its primary endpoint of a statistically significant improvement in progression-free survival. The study, called DECISION, evaluated the efficacy and safety of Nexavar compared to placebo. The safety and tolerability were generally consistent with the known profile of Nexavar. Detailed efficacy and safety analysis from this study are expected to be presented at an upcoming medical meeting. Effective treatment options are urgently needed for patients with RAI-refractory differentiated thyroid cancer,” said Dimitris Voliotis, MD, Vice President, Global Clinical Development Oncology, Bayer HealthCare. “We are pleased that the results of this study demonstrate that Nexavar may provide a treatment option for these patients.

Bulk Drug

Health Care

Alternative Medicine

Eye Care

Dr Shroff’s Charity Eye Hospital and Standard Chartered, to host the 1st International Optometry...

New Delhi, December 29,  2023 :   Dr Shroff’s Charity Eye Hospital together with Standard Chartered is organising India’s first International Optometry and Vision Science...

Seeing the world differently :Eye Donation Fortnight By Dr. Shibu Varkey- Dr. Shibu Varkey,...

The realm of ophthalmology stands witness to remarkable advancements in medical science that have revolutionized the treatment of visual impairments. However, amidst the array...

Product News

Media Partners

Spotlight

Investments

Packaging

Latest News

GLocalMind, leading global healthcare fieldwork and analysis company from India completes 10-year milestone’.

New Delhi, December 12, 2020: GLocalMind, a leading healthcare fieldwork and analysis company serving the healthcare ecosystem has successfully completed 10 years in the...

Kinetic Launches their UV Warrior Product Range; UVC Light Based Sanitizer that Kills...

Pune, November 10, 2020: Kinetic Communications Limited; part of the Kinetic Group, launches the UV WARRIOR - a portable disinfector that sanitises all daily...

SirionLabs Launches SirionAE, an AI-driven Data Extraction Platform that Reduces the High Cost of...

Using machine learning algorithms that analyze more than 1 Million contracts per day, new product helps businesses pull key insights from contracts to improve...

Thalassemia a blood disorder considered as a disability, can be treated with a Stem...

DKMS-BMST brings hope to Thalassemia patients by helping them in finding a matching stem cell donor  Bengaluru, December 02, 2022: Thalassemia is a blood disorder,...

Dental Care

Hospital Management

Drug Discovery & Development

Suppliers

Technology

Companies

LIVE Demo on Microneedling Techniques by Dr. Ajay Rana in LIVE...

Expert faculties providing online training to enhance the skills of students … New Delhi, May 23, 2020: In the series of LIVE online sessions of...

World Marrow Donor Day: Blood stem cell donation helping blood cancer...

DKMS-BMST thanks the blood stem cell donors worldwide  Bengaluru, September 19, 2020: September 19th is observed as World Marrow Donor Day, a day celebrated to thank...

Marketing

Our Partners

Machinery & Equipments